PHARMATHENE INC

Medical/Disease research and work with clinical labs

Active 2007–2017. The register lists this client once for every firm that files on its behalf; all 7 of its records are shown together here.

Filings
114
Filed By
7
Reported In-House
$4,191,452
Reported By Firms
$1,787,550

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2008 FOLEY HOAG LLP 4th Quarter (Oct 1 - Dec 31)
AMENDED
$30,000
2008 FOLEY HOAG LLP 4th Quarter (Oct 1 - Dec 31)
AMENDED
$30,000
2008 PHARMATHENE, INC 3rd Quarter (July 1 - Sep 30)
AMENDED
$207,464
2008 PHARMATHENE, INC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Termination
$207,464
2008 PHARMATHENE, INC 4th Quarter (Oct 1 - Dec 31)
AMENDED
$177,760
2008 HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$20,000
2008 DENTONS US LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$30,000
2008 FOLEY HOAG LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$30,000
2008 ERVIN GRAVES STRATEGY GROUP, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$50,000
2008 DENTONS US LLP 4th Quarter (Oct 1 - Dec 31)
Registration
—
Page 1 of 3  ·  23 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings